Bgi Genomics Co.,Ltd.’s Net Profit Dropped 90.6% in First Three Quarters of 2023

Bgi Genomics Co.,Ltd. (深圳华大基因股份有限公司) (300676.SZ) reported a net profit of 70.1 million yuan in the first three quarters of 2023, down 90.6% year-on-year.

Meanwhile, the company posted 3.1 billion yuan in revenue, down 30.4% year-on-year.

At the end of the reporting period, it had 13.5 billion yuan in total assets and 3.4 billion yuan in total liabilities, with a liability-to-asset ratio of 25%.